Authorization

Angion to Participate in Upcoming March Investment Conferences

UNIONDALE, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, today announced its management team will present at the H.C. Wainwright Global Life Sciences Conference and the Oppenheimer 31st Annual Healthcare Conference. Dr. Jay Venkatesan, Angiona??s President and CEO, will also participate in a panel focused on kidney diseases at the Cowen 41st Annual Health Care Conference. All three virtual investor conferences will take place in March 2021.
Details are as follows:Event:Cowen 41st Annual Health Care Conference
Date: Wednesday, March 3rd
Time: 3:20pm Eastern US TimeEvent:HC Wainwright Global Life Sciences Conference
Date: Tuesday, March 9th
Time: 7:00am Eastern US TimeEvent:Oppenheimer 31st Annual Healthcare Conference
Date: Thursday, March 18th
Time: 10:40am Eastern US Time
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2021    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
2627282930